A panel of experts advising the Food and Drug Administration will weigh the safety and effectiveness of the COVID-19 vaccine from Pfizer and BioNTech in a daylong public meeting. The committee will vote on whether the FDA should authorize the vaccine for emergency use during the pandemic.
© 2026 90.3 KAZU
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations